| Nasdaq: DRAD
Digirad Corp. provides in-office nuclear cardiology imaging and ultrasound services to physician practices, hospitals and imaging centers through its Digirad Imaging Solutions business segment. It also sells medical diagnostic imaging systems including solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products. The company designs and commercializes the solid-state nuclear gamma camera for the detection of cardiovascular disease and other medical conditions. It operates through two segments: Digirad Imaging Solutions and Diagnostic Imaging segment. The Digirad Imaging Solutions segment offers a comprehensive diagnostic imaging services program as an alternative to purchasing a gamma camera or ultrasound equipment for physicians to perform nuclear imaging, echocardiography, vascular ultrasound, or any combination of these procedures in their offices by leasing the imaging system, certified personnel and other support required to perform imaging in the physician's office. These segments services are primarily provided to cardiologists, internal medicine physicians and family practice doctors who enter into annual contracts for its diagnostic imaging services delivered on a per-day basis. The Diagnostic Imaging segment engages in selling solid-state gamma cameras and camera maintenance contracts. It sells imaging systems to physician offices and hospitals primarily in the United States. The company founded in 1997 and is headquartered in Poway, CA.